Eastern Bank’s Zimmer Biomet ZBH Stock Holding History

Eastern Bank’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$270K	Hold	3,140	–	–	﹤0.01%	361
2026 Q1	$284K	Sell	3,140 -600	-16%	-$55.1K	﹤0.01%	331
2025 Q4	$336K	Buy	3,740 +160	+4%	+$15.2K	0.01%	301
2025 Q3	$353K	Buy	3,580 +40	+1%	+$3.96K	0.01%	296
2025 Q2	$323K	Hold	3,540	–	–	0.01%	301
2025 Q1	$401K	Hold	3,540	–	–	0.01%	289
2024 Q4	$374K	Hold	3,540	–	–	0.01%	294
2024 Q3	$382K	Buy	+3,540	New	+$386K	0.01%	304

Other funds holding ZBH

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

DJSG

D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

QAM

QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

NCM

Northside Capital Management Hood River, Oregon $1.22B AUM 20.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

GHAM

Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Eastern Bank's ZBH Position: Q2 2026 in Review

Eastern Bank held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 3,140 shares worth $270K. The position accounts for ﹤0.01% of the portfolio, ranked #361.

Eastern Bank first reported a position in ZBH in Q3 2024 and has held it in 8 quarters since. The position peaked at $401K in Q1 2025. 140 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Eastern Bank held 3,140 shares of Zimmer Biomet worth $270K as of Q2 2026.
Eastern Bank left its Zimmer Biomet share count unchanged in Q2 2026.
Zimmer Biomet made up ﹤0.01% of Eastern Bank's portfolio in Q2 2026, its #361 holding.
Eastern Bank first reported a position in Zimmer Biomet in Q3 2024 and has held it in 8 quarters since.
Eastern Bank's Zimmer Biomet position peaked at $401K in Q1 2025.
140 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.